Myositis autoantibodies and clinical phenotypes

Autoimmunity Highlights

Volumn 5, Issue 3, 2014, Pages 69-75

  Ghirardello, Anna ^a   Borella, Elisabetta ^a   Beggio, Marianna ^a   Franceschini, Franco ^b   Fredi, Micaela ^b,c   Doria, Andrea ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b SPEDALI CIVILI   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Autoantibodies; Autoimmune myositis; Myositis specific antibodies; Overlap syndrome

Indexed keywords

AMINO ACID TRANSFER RNA LIGASE ANTIBODY; AUTOANTIBODY; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE ANTIBODY; MELANOMA DIFFERENTIATION ASSOCIATED PROTEIN 5 ANTIBODY; MI 2 ANTIBODY; MYOSITIS ASSOCIATED AUTOANTIBODY; MYOSITIS SPECIFIC AUTOANTIBODY; NUCLEAR MATRIX PROTEIN 2 ANTIBODY; SIGNAL RECOGNITION PARTICLE ANTIBODY; SMALL NUCLEAR RIBONUCLEOPROTEIN ANTIBODY; STEROID RECEPTOR COACTIVATOR 1 ANTIBODY; SUMO 1 PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIGEN EXPRESSION; CONNECTIVE TISSUE DISEASE; DERMATOMYOSITIS; DISEASE ASSOCIATION; HISTOPATHOLOGY; HUMAN; IMMUNOBLOTTING; INFLAMMATORY INFILTRATE; INTERSTITIAL LUNG DISEASE; MUSCLE BIOPSY; MUSCLE NECROSIS; PATHOGENESIS; PERIMYSIUM; PHENOTYPE; POLYMYOSITIS; REVIEW; ROUGH ENDOPLASMIC RETICULUM; SCLERODERMA; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 84912050349     PISSN: 20380305     EISSN: 20383274     Source Type: Journal    
DOI: 10.1007/s13317-014-0060-4     Document Type: Review

References (27)

1. Ghirardello A, Bassi N, Palma L et al (2013) Autoantibodies in polymyositis and dermatomyositis. Curr Rheumatol Rep 15:335. doi:10.1007/s11926-013-0335-1
2. Iaccarino L, Gatto M, Bettio S et al (2012) Overlap connective tissue disease syndromes. Autoimmun Rev 3:363–373
3. Zampieri S, Ghirardello A, Iaccarino L, Tarricone E, Gambari PF, Doria A (2005) Anti-Jo-1 antibodies. Autoimmunity 38:73–78
4. Ghirardello A, Zampieri S, Iaccarino L et al (2005) Anti-Mi-2 autoantibodies. Autoimmunity 38:79–83
5. Hengstman GJ, ter Laak HJ, Vree Egberts WT et al (2006) Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy. Ann Rheum Dis 65:1635–1638
6. Trallero-Araguas E, Rodrigo-Pendas JA, Selva-O’Challagan A et al (2012) Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis. A systematic review and meta-analysis. Arthritis Rheum 64:523–532
7. Fiorentino DF, Chung LS, Christopher-Stine L et al (2013) Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1 γ. Arthritis Rheum 65:2954–2962. doi:10.1002/art.38093
8. Cao H, Pan M, Kang Y et al (2012) Clinical manifestations of dermatomyositis and clinically amyopathic dermatomyositis patients with positive expression of anti-melanoma differentiation-associated gene 5 antibody. Arthritis Care Res 64:1602–1610
9. Hall JC, Casciola-Rosen L, Samedy LA et al (2013) Anti-melanoma differentiation-associated protein 5-associated dermatomyositis: expanding the clinical spectrum. Arthritis Care Res 65:1307–1315. doi:10.1002/acr.21992
10. Tarricone E, Ghirardello A, Rampudda M, Bassi N, Punzi L, Doria A (2012) Anti-SAE antibodies in autoimmune myositis: identification by unlabelled protein immunoprecipitation in an Italian patient cohort. J Immunol Methods 384:128–134
11. Mohassel P, Mammen AL (2013) Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies. Muscle Nerve 48:477–483. doi:10.1002/mus.23854
12. Mahler M, Miller FW, Fritzler MJ (2014) Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review. Autoimmun Rev 13:367–371. doi:10.1016/j.autrev.2014.01.022
13. Iaccarino L, Ghirardello A, Bettio S et al (2014) The clinical features, diagnosis and classification of dermatomyositis. J Autoimmun 48–49:122–127. doi:10.1016/j.jaut.2013.11.005
14. Ceribelli A, Fredi M, Taraborelli M et al (2012) Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis. Arthritis Res Ther 14:R97. doi:10.1186/ar3822
15. Troyanov Y, Targoff IN, Tremblay JL, Goulet JR, Raymond Y, Senécal JL (2005) Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients. Medicine (Baltimore). 84:231–249
16. Marie I, Hatron PY, Dominique S et al (2012) Short-term and long-term outcome of anti-Jo1-positive patients with anti-Ro52 antibody. Semin Arthritis Rheum 41:890–899
17. Váncsa A, Gergely L, Ponyi A et al (2010) Myositis-specific and myositis-associated antibodies in overlap myositis in comparison to primary dermatopolymyositis: Relevance for clinical classification: retrospective study of 169 patients. Jt Bone Spine 77:125–130
18. Mahler M, Raijmakers R (2007) Novel aspects of antibodies to the PM/Scl complex: clinical, genetics and diagnostic insights. Autoimmun Rev 6:432–437
19. Lega JC, Cottin V, Fabien N, Thivolet-Béjui F, Cordier JF (2010) Interstitial lung disease associated with anti-PM/Scl or anti-aminoacyl-tRNA synthetase autoantibodies: a similar condition? J Rheumatol 37:1000–1009
20. Cavazzana I, Fredi M, Taraborelli M, Quinzanini M, Tincani A, Franceschini F (2013) A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies. Clin Exp Rheumatol 31:118–121
21. Rigolet A, Musset L, Dubourg O et al (2012) Inflammatory myopathies with anti-Ku antibodies: a prognosis dependent on associated lung disease. Medicine (Baltimore) 91:95–102
22. Ho KT, Reveille JD (2003) The clinical significance of autoantibodies in scleroderma. Arthritis Res Ther 5:80–93
23. Dayal NA, Isenberg DA (2002) SLE/myositis overlap: are the manifestations of SLE different in overlap disease? Lupus 11:293–298
24. Ghirardello A, Rampudda M, Ekholm L et al (2010) Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay. Rheumatology (Oxford) 49:2370–2374
25. Casciola-Rosen L, Nagaraij K, Plots P et al (2005) Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy. J Exp Med 201:591–601
26. Zampieri S, Doria A, Adami N et al (2010) Subclinical myopathy in patients affected with early stage colorectal cancer at disease onset: evidence from skeletal muscle biopsies. Neurol Res 32:20–25
27. Lundberg IE, Helmers SB (2010) The type I interferon system in idiopathic inflammatory myopathies. Autoimmunity 43:239–243